Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexamethylbenzene SCHEMBL9577265 | 1.00 | RXFP1 (0.31) | RXFP1 | |
| Hexamethylbenzene SCHEMBL14954279 | 0.93 | — | — | |
| Hexamethylbenzene SCHEMBL3999978 | 0.93 | — | — | |
| Hexamethylbenzene SCHEMBL114857 | 0.91 | RXFP1 (0.33) | RXFP1 | |
| Hexamethylbenzene SCHEMBL10608743 | 0.83 | RXFP1 (0.31) | RXFP1 | |
| Hexamethylbenzene SCHEMBL10952799 | 0.83 | RXFP1 (0.31) | RXFP1 | |
| Hexamethylbenzene SCHEMBL9419367 | 0.83 | RXFP1 (0.31) | RXFP1 | |
| Hexamethylbenzene SCHEMBL3853890 | 0.83 | RXFP1 (0.31) | RXFP1 | |
| Hexamethylbenzene SCHEMBL10952629 | 0.83 | RXFP1 (0.31) | RXFP1 | |
| Hexamethylbenzene SCHEMBL10609849 | 0.83 | RXFP1 (0.31) | RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002040494-A1 | RUTHENIUM-ARYL-COMPOUNDS IN CANCER THERAPY | UNIVERSITY OF YORK (GB) | 2002-05-23 | — | — | WO | claimed |
| EP-2865446-B1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE SECONDARY ALCOHOL | KANTO KAGAKU (JP) | 2021-09-22 | — | — | EP | disclosed |
| US-9174906-B2 | Process for producing optically active secondary alcohol | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2015-11-03 | — | — | US | disclosed |
| EP-2865446-A1 | Process for producing optically active secondary alcohol | Kanto Kagaku Kabushiki Kaisha (JP) | 2015-04-29 | — | — | EP | disclosed |
| US-20150031920-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE SECONDARY ALCOHOL | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2015-01-29 | — | — | US | disclosed |
| US-8722912-B2 | Metal complex compound and process for producing amides utilizing the metal complex compound | NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) | 2014-05-13 | — | — | US | disclosed |
| US-20130131366-A1 | Metal Complex Compound and Process for Producing Amides Utilizing the Metal Complex Compound | NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) | 2013-05-23 | — | — | US | disclosed |
| CN-101646678-B | heteroaryl derivatives | NIPPON SHINYAKU CO LTD | 2012-05-30 | — | — | CN | disclosed |
| CN-102234294-A | Novel process for preparing (C6Me6)2Ru organic metal complex | UNIV BEIJING CHEMICAL | 2011-11-09 | — | — | CN | disclosed |
| CN-101646678-A | Heteroaryl Derivatives | NIPPON SHINYAKU CO LTD JP | 2010-02-10 | — | — | CN | disclosed |
| US-7332622-B2 | Process for preparing optically active nitro compounds and cyano compounds | KANTO KAGUKU KABUSHIKI KAISHA (JP) | 2008-02-19 | — | — | US | disclosed |
| EP-1439159-B1 | Process for producing optically active compound | KANTO KAGAKU (JP) | 2007-06-20 | — | — | EP | disclosed |
| EP-1308435-B1 | Process for producing optically active amino alcohols | KANTO KAGAKU (JP) | 2005-12-28 | — | — | EP | disclosed |
| CN-1626501-A | Process for preparing optically active nitro compounds and cyano compounds | KANTO KAGAKU (JP) | 2005-06-15 | — | — | CN | disclosed |
| US-20050101787-A1 | Process for preparing optically active nitro compounds and cyano compounds | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2005-05-12 | — | — | US | disclosed |
| EP-1512678-A1 | Process for preparing optically active nitro compounds and cyano compounds | Kanto Kagaku Kabushiki Kaisha (JP) | 2005-03-09 | — | — | EP | disclosed |
| EP-1439159-A1 | Process for producing optically active compound | Kanto Kagaku Kabushiki Kaisha (JP) | 2004-07-21 | — | — | EP | disclosed |
| EP-1308435-A2 | Process for producing optically active amino alcohols | Kanto Kagaku Kabushiki Kaisha (JP) | 2003-05-07 | — | — | EP | disclosed |
| WO-2002040494-A1 | RUTHENIUM-ARYL-COMPOUNDS IN CANCER THERAPY | UNIVERSITY OF YORK (GB) | 2002-05-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150031920-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE SECONDARY ALCOHOL | ADH1A, ADH1C, ADH5 | RXFP1 2289/4885 |
| US-20130131366-A1 | Metal Complex Compound and Process for Producing Amides Utilizing the Metal Complex Compound | AP2M1, ASH2L, AP2A1 | RXFP1 3213/4885 |
| US-20050101787-A1 | Process for preparing optically active nitro compounds and cyano compounds | NOS1, NOS2, NOX1 | RXFP1 3833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.